Guadalupe Oñate

9PUBLICATIONS
49CO-AUTHORS
Medical mycologyGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 02, 2026
Measurable Residual Disease in IDH-Mutated AML: Identifying a Clinically Relevant Threshold for IDH Mutation Monitoring.

|Oct 14, 2026
Rapid molecular screening of adult AML: Experience from the Spanish CETLAM cooperative group.

|Feb 09, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Rabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|Nov 09, 2024
Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome.

Jonas El Bachouti, Anna Domínguez-Guasch, Yolanda Arce

|May 05, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Guadalupe Oñate, Marta Pratcorona, Ana Garrido

Pageof 2

Frequent Collaborators

5 joint publications

Jordi Esteve

4 joint publications

Marta Pratcorona

4 joint publications

Jorge Sierra

4 joint publications

Antònia Sampol